IL229178B

Pyruvate kinase activators compounds for use in therating disease

Abstract

This record has no abstract on file.

Term

No projected expiry on record.

  1. Priority
  2. Filed
  3. Published
  4. Today

94 members in 29 offices

This recordMember, by publication datePriority claim19 more offices are in the list below

Priority claims2

Priority claims
DocumentOfficeKindDate
201161482171United States of AmericaP
2012036412United States of AmericaW

Members94

Family members, oldest first
DocumentOfficeKind
CA2834602A1CanadaA1
CA3088328A1CanadaA1
WO2012151451A1World Intellectual Property Organization (WIPO)A1
AU2012250688A1AustraliaA1
SG194697A1SingaporeA1
IL229178A0IsraelA0
IL229178D0IsraelD0
PH12013502241A1PhilippinesA1
KR20140028008ARepublic of KoreaA
EP2704721A1European Patent Office (EPO)A1
CN103764147AChinaA
JP2014513133AJapanA
MX2013012787AMexicoA
US2014194402A1United States of AmericaA1
RU2013153388ARussian FederationA
US9193701B2United States of AmericaB2
US2016106742A1United States of AmericaA1
ZA201308012BSouth AfricaB
SG10201609196QASingaporeA
JP2017019839AJapanA
AU2012250688B2AustraliaB2
US9682080B2United States of AmericaB2
AU2017221860A1AustraliaA1
US2017290825A1United States of AmericaA1
JP6272754B2JapanB2
JP6272967B2JapanB2
PH12017501176A1PhilippinesA1
JP2018027985AJapanA
EP2704721B1European Patent Office (EPO)B1
CN103764147BChinaB
US9980961B2United States of AmericaB2
PT2704721TPortugalT
KR101873543B1Republic of KoreaB1
BR112013028422A2BrazilA2
DK2704721T3DenmarkT3
KR20180079451ARepublic of KoreaA
LT2704721TLithuaniaT
ES2675903T3SpainT3
TR2018009699T4TürkiyeT4
TR201809699T4TürkiyeT4
HRP20180863T1CroatiaT1
CN108451955AChinaA
RS57342B1SerbiaB1
SI2704721T1SloveniaT1
SMT201800354T1San MarinoT1
PL2704721T3PolandT3
EP3406251A1European Patent Office (EPO)A1
US2018338970A1United States of AmericaA1
RU2675656C2Russian FederationC2
HUE039269T2HungaryT2
ME03074BMontenegroB
RU2017145066ARussian FederationA
CY1120374T1CyprusT1
MX367387BMexicoB
PH12016501710A1PhilippinesA1
KR102024027B1Republic of KoreaB1
MX2019009856AMexicoA
AU2017221860B2AustraliaB2
JP6603293B2JapanB2
AU2020200700A1AustraliaA1
US10632114B2United States of AmericaB2
IL229178AIsraelA
IL229178BThis recordIsraelB
US2020289502A1United States of AmericaA1
IL276414AIsraelA
IL276414D0IsraelD0
CA2834602CCanadaC
RU2017145066A3Russian FederationA3
US2021220351A1United States of AmericaA1
BR112013028422B1BrazilB1
BR112013028422B8BrazilB8
CN108451955BChinaB
AU2020200700B2AustraliaB2
CN114432312AChinaA
PH12017501176B1PhilippinesB1
IL276414B2IsraelB2
US11793806B2United States of AmericaB2
EP3406251B1European Patent Office (EPO)B1
PT3406251TPortugalT
LT3406251TLithuaniaT
FI3406251T3FinlandT3
DK3406251T3DenmarkT3
SMT202400081T1San MarinoT1
RS65215B1SerbiaB1
HRP20240225T1CroatiaT1
PL3406251T3PolandT3
ES2970938T3SpainT3
SI3406251T1SloveniaT1
HUE065700T2HungaryT2
CN114432312BChinaB
US2024277701A1United States of AmericaA1
MX386224BMexicoB
US12377093B2United States of AmericaB2
US2025332161A1United States of AmericaA1